Reduced intensity conditioning of allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myeloid leukemia in patients older than 50 years of age: a systematic review and meta-analysis.

Zhi-Hui ZhangXin-Yue LianDong-Ming YaoPin-Fang HeJi-Chun MaZi-Jun XuHong GuoWei ZhangJiang LinZhi-Hui Zhang

Published in: Journal of cancer research and clinical oncology (2017)

RIC-alloHSCT is a feasible treatment option for the patients older than 50 year of age with MDS and AML. Advanced diseases status and higher diseases risk may be the poor factors for prognosis.

Keyphrases

acute myeloid leukemia
allogeneic hematopoietic stem cell transplantation
end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
peritoneal dialysis
physical activity
acute lymphoblastic leukemia
patient reported outcomes
community dwelling
replacement therapy